Skip to main content
Clinical Trials/NCT05569785
NCT05569785
Recruiting
Not Applicable

Exploring the Short-Term Effect of Bariatric Surgery on Muscle Structure And Function; Followed By A Feasibility Assessment Of Exercise Intervention Post Bariatric Surgery

University of Nottingham1 site in 1 country12 target enrollmentMarch 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bariatric Surgery Candidate
Sponsor
University of Nottingham
Enrollment
12
Locations
1
Primary Endpoint
Assessment of percentage of patients who were retained throughout the intervention arm of the study
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.

Detailed Description

A single-centre feasibility research programme based at the Royal Derby Hospital centre of the University of Nottingham. This is an exploratory and feasibility study. Muscle structure and function of 12 patients will be assessed before bariatric surgery and at 6 weeks, and then 10 weeks, after surgery. After 6 weeks, participants will be randomised into two groups. Group 1 will undergo a 4 week Resistance Exercise Training (RET). Group 2 will undergo standard care procedure. The total duration of programme we are aiming for is 13-14 weeks prior to bariatric surgery and exercise intervention for 4 weeks after bariatric surgery.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
December 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Obese adults (BMI greater than or equal to 35 kg/m2)
  • Age range 18-70 years old
  • Scheduled for RYGB surgery or sleeve gastrectomy surgery.
  • Ability to give informed consent

Exclusion Criteria

  • Patients who are not fit or not suitable for RYGB or Sleeve Gastrectomy as per Tier 4 Bariatric Surgery MDT.
  • For those high-risk patients who are fast tracked to surgery, we will exclude patients with a NYHA \>3 or 4 heart failure status and those with end stage renal failure.
  • BMI greater than or equal to 60

Outcomes

Primary Outcomes

Assessment of percentage of patients who were retained throughout the intervention arm of the study

Time Frame: Total duration of study per participant is expected to be 13 to 14 weeks

To be measured as percentage.

Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use.

Time Frame: Total duration of study per participant is expected to be 13 to 14 weeks

This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study.

To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness.

Time Frame: Total duration of study per participant is expected to be 13 to 14 weeks

This will be assessed using muscle ultrasound and units (mm)

To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2)

Time Frame: Total duration of study per participant is expected to be 13 to 14 weeks

This will be assessed using muscle ultrasound

Assessment of number of patients who were recruited to the study

Time Frame: Total duration of study per participant is expected to be 13 to 14 weeks

This assessment will be measured as a simple numeric value

Secondary Outcomes

  • Fasting glucose(Total duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface.)
  • Skeletal muscle architecture (fibre length)(Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day)
  • Muscle fatigability (maximum voluntary contractions)(Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days.)
  • Balance using the Timed Up and Go (TUG) test(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Balance in Gait and Motion testing(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Hand grip strength(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Lean body mass using BIA and D3 creatine(Total duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later..)
  • Motor control in force tracking(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Predicted maximum oxygen consumption (VO2 max) in step box test(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Skin fold and body circumference measurements(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Quality of life measurements using IPAQ questionnaire(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Skeletal muscle architecture (pennation angle)(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • insulin resistance (HOMA-IR)(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)
  • Quality of life measurements using SF-36 questionnaire(Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.)

Study Sites (1)

Loading locations...

Similar Trials